245 related articles for article (PubMed ID: 31559369)
21. Genetic Testing for Hereditary Nonpolyposis Colorectal Cancer (HNPCC).
Nallamilli BRR; Hegde M
Curr Protoc Hum Genet; 2017 Jul; 94():10.12.1-10.12.23. PubMed ID: 28696559
[TBL] [Abstract][Full Text] [Related]
22. Lynch Syndrome Screening in the Gynecologic Tract: Current State of the Art.
Mills AM; Longacre TA
Am J Surg Pathol; 2016 Apr; 40(4):e35-44. PubMed ID: 26872009
[TBL] [Abstract][Full Text] [Related]
23. Universal Versus Targeted Screening for Lynch Syndrome: Comparing Ascertainment and Costs Based on Clinical Experience.
Erten MZ; Fernandez LP; Ng HK; McKinnon WC; Heald B; Koliba CJ; Greenblatt MS
Dig Dis Sci; 2016 Oct; 61(10):2887-2895. PubMed ID: 27384051
[TBL] [Abstract][Full Text] [Related]
24. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome.
Dove-Edwin I; de Jong AE; Adams J; Mesher D; Lipton L; Sasieni P; Vasen HF; Thomas HJ
Gastroenterology; 2006 Jun; 130(7):1995-2000. PubMed ID: 16762622
[TBL] [Abstract][Full Text] [Related]
25. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review.
Lindor NM; Petersen GM; Hadley DW; Kinney AY; Miesfeldt S; Lu KH; Lynch P; Burke W; Press N
JAMA; 2006 Sep; 296(12):1507-17. PubMed ID: 17003399
[TBL] [Abstract][Full Text] [Related]
26. Lynch syndrome in upper tract urothelial carcinoma: significance, screening, and surveillance.
Pradere B; Lotan Y; Roupret M
Curr Opin Urol; 2017 Jan; 27(1):48-55. PubMed ID: 27533503
[TBL] [Abstract][Full Text] [Related]
27. Understanding Lynch syndrome: implications for nursing.
Bannon E; Coleman EA
Clin J Oncol Nurs; 2007 Jun; 11(3):423-7. PubMed ID: 17623626
[TBL] [Abstract][Full Text] [Related]
28. Current clinical topics of Lynch syndrome.
Tanakaya K
Int J Clin Oncol; 2019 Sep; 24(9):1013-1019. PubMed ID: 29744602
[TBL] [Abstract][Full Text] [Related]
29. Lynch Syndrome/Hereditary Non-polyposis Colorectal Cancer (HNPCC).
Stoffel EM
Minerva Gastroenterol Dietol; 2010 Mar; 56(1):45-53. PubMed ID: 20190724
[TBL] [Abstract][Full Text] [Related]
30. Identification of MSH2 inversion of exons 1-7 in clinical evaluation of families with suspected Lynch syndrome.
Mork ME; Rodriguez A; Taggart MW; Rodriguez-Bigas MA; Lynch PM; Bannon SA; You YN; Vilar E
Fam Cancer; 2017 Jul; 16(3):357-361. PubMed ID: 28004223
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic features of endometrial cancer with mismatch repair deficiency.
Gordhandas S; Kahn RM; Gamble C; Talukdar N; Maddy B; Baltich Nelson B; Askin G; Christos PJ; Holcomb K; Caputo TA; Chapman-Davis E; Frey MK
Ecancermedicalscience; 2020; 14():1061. PubMed ID: 32582376
[TBL] [Abstract][Full Text] [Related]
32. Mismatch repair gone awry: Management of Lynch syndrome.
Zhang T; Boswell EL; McCall SJ; Hsu DS
Crit Rev Oncol Hematol; 2015 Mar; 93(3):170-9. PubMed ID: 25459670
[TBL] [Abstract][Full Text] [Related]
33. Mismatch repair deficiency testing in clinical practice.
Buza N; Ziai J; Hui P
Expert Rev Mol Diagn; 2016; 16(5):591-604. PubMed ID: 26895074
[TBL] [Abstract][Full Text] [Related]
34. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.
Lagerstedt-Robinson K; Rohlin A; Aravidis C; Melin B; Nordling M; Stenmark-Askmalm M; Lindblom A; Nilbert M
Oncol Rep; 2016 Nov; 36(5):2823-2835. PubMed ID: 27601186
[TBL] [Abstract][Full Text] [Related]
35. Utility of immunohistochemistry for mismatch repair proteins on colorectal polyps in the familial cancer clinic.
Dow E; Buchanan DD; Winship IM
Intern Med J; 2018 Nov; 48(11):1325-1330. PubMed ID: 29717530
[TBL] [Abstract][Full Text] [Related]
36. Achieving behaviour change for detection of Lynch syndrome using the Theoretical Domains Framework Implementation (TDFI) approach: a study protocol.
Taylor N; Long JC; Debono D; Williams R; Salisbury E; O'Neill S; Eykman E; Braithwaite J; Chin M
BMC Health Serv Res; 2016 Mar; 16():89. PubMed ID: 26969429
[TBL] [Abstract][Full Text] [Related]
37. Lynch Syndrome: A Primer for Urologists and Panel Recommendations.
Mork M; Hubosky SG; Rouprêt M; Margulis V; Raman J; Lotan Y; O'Brien T; You N; Shariat SF; Matin SF
J Urol; 2015 Jul; 194(1):21-9. PubMed ID: 25711197
[TBL] [Abstract][Full Text] [Related]
38. Etiology, natural history, management and molecular genetics of hereditary nonpolyposis colorectal cancer (Lynch syndromes): genetic counseling implications.
Lynch HT; Lemon SJ; Karr B; Franklin B; Lynch JF; Watson P; Tinley S; Lerman C; Carter C
Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):987-91. PubMed ID: 9419392
[TBL] [Abstract][Full Text] [Related]
39. [Lynch syndrome: What is new?].
Pellat A; Netter J; Perkins G; Cohen R; Coulet F; Parc Y; Svrcek M; Duval A; André T
Bull Cancer; 2019; 106(7-8):647-655. PubMed ID: 30527816
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
